Double Dippers in Clinical Trials: A Risk to Research Integrity and Patient Safety

Project Optimus: Oncology Podcast

Bridging disciplines: The journey of hierarchical clinical endpoints (HCE) in cardiovascular and renal trials

How hierarchical clinical endpoints can support cardiovascular and renal clinical trials as explained in a Q&A with Fortrea leaders in nephrology, cardiovascular and biostatistics

Biostatistics and Statistical Programming

Global Clinical Data Management

FSP Clinical Operations

Functional Service Provider

Fortrea FSP model helps manage clinical operations and clinical trials with greater efficiency and flexibility through tailored functional service solutions.

Creating site and patient centric solutions for a challenging antibiotic pharmacokinetic (PK) study

Beyond the Headlines: What ASCO 2025 Taught Us About the Future of Cancer Care

FDA Animal Testing Alternatives & Nonclinical Drug Development Strategy

In April 2025, the U.S. Food and Drug Administration (FDA) announced its intention to phase out animal testing requirements for monoclonal antibodies and other pharmaceuticals . While this milestone signals progress toward more ethical and innovative drug development approaches, its implications warrant careful examination.